American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 379-395 , September 2007

Balancing Fistula First With Catheters Last

  • Eduardo Lacson Jr, MD, MPH

      Affiliations

    • Fresenius Medical Care, North America, Waltham, MA
    • Corresponding Author InformationAddress correspondence to Eduardo Lacson Jr, MD, MPH, Vice President, Clinical Science, Epidemiology, and Research, Fresenius Medical Care, North America, 920 Winter St, Waltham, MA 02451-1457.
    • ,
  • J. Michael Lazarus, MD

      Affiliations

    • Fresenius Medical Care, North America, Waltham, MA
    • ,
  • Jonathan Himmelfarb, MD

      Affiliations

    • Maine Medical Center, Portland, ME
    • ,
  • T. Alp Ikizler, MD

      Affiliations

    • Vanderbilt University Medical Center, Nashville, TN.
    • ,
  • Raymond M. Hakim, MD

      Affiliations

    • Fresenius Medical Care, North America, Waltham, MA

Received 5 February 2007 ,Accepted 15 June 2007.

References 

  1. National Kidney Foundation. DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis. 1997;30(suppl 3):S150–S191
  2. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis. 2001;37(suppl 1):S137–S181
  3. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations; 2006 Updates: Vascular Access. Am J Kidney Dis. 2006;48(suppl 1):S176–S307
  4. Peters VJ, Clemons G, Augustine B. “Fistula First” as a CMS breakthrough initiative: Improving vascular access through collaboration. Nephrol Nurs J. 2005;32:686–687
  5. Centers for Medicare & Medicaid Services: Press release dated March 31, 2006. Available at: http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=1818. Accessed December 15, 2006
  6. Centers for Medicare & Medicaid Services. 2005 Annual Report, End-Stage Renal Disease Clinical Performance Measures Project. Baltimore, MD: Department of Health and Human Services, Centers for Medicare & Medicaid Services, Office of Clinical Standards and Quality; 2005;
  7. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000;57:639–645
  8. Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: The CHOICE Study. Am J Kidney Dis. 2001;38:494–501
  9. Avorn J, Winkelmayer WC, Bohn RL, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55:711–716
  10. Harwood L, Locking-Cusolito H, Spittal J, Wilson B, White S. Preparing for hemodialysis: Patient stressors and responses. Nephrol Nurs J. 2005;32:295–302
  11. Sands JJ, Perry MA. Improving vascular access outcomes: A systems approach to eliminating structural barriers. Blood Purif. 2003;21:111–117
  12. O’Hare AM, Bertenthal D, Walter LC, et al. When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration?. Kidney Int. 2007;71:555–561
  13. Corpataux JM, Haesler E, Silacci P, Ris HB, Hayoz D. Low-pressure environment and remodeling of the forearm vein in Brescia-Cimino haemodialysis access. Nephrol Dial Transplant. 2002;17:1057–1062
  14. Masuda H, Zhuang YJ, Singh TM, et al. Adaptive remodeling of internal elastic lamina and endothelial lining during flow-induced arterial enlargement. Arterioscler Thromb Vasc Biol. 1999;19:2298–2307
  15. Rayner HC, Pisoni RL, Gillespie BW, et al. Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2003;63:323–330
  16. Patel ST, Hughes J, Mills JL. Failure of arteriovenous fistula maturation: An unintended consequence of exceeding Dialysis Outcome Quality Initiative guidelines for hemodialysis access. J Vasc Surg. 2003;38:439–445
  17. Kian K, Vassalotti JA. The new arteriovenous fistula: The need for earlier evaluation and intervention. Semin Dial. 2005;18:3–7
  18. Beathard GA. An algorithm for the physical examination of early fistula failure. Semin Dial. 2005;18:331–335
  19. Dixon BS. Why don’t fistulas mature?. Kidney Int. 2006;70:1413–1422
  20. Wolford HY, Hsu J, Rhodes JM, et al. Outcome after autogenous brachial-basilic upper arm transpositions in the post-National Kidney Foundation Dialysis Outcomes Quality Initiative era. J Vasc Surg. 2005;42:951–956
  21. Fitzgerald JT, Schanzer A, Chin AI, McVicar JP, Perez RV, Troppmann C. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg. 2004;139:201–208
  22. Feldman HI, Joffe M, Rosas SE, Burns JE, Knauss J, Brayman K. Predictors of successful arteriovenous fistula maturation. Am J Kidney Dis. 2003;42:1000–1012
  23. Fullerton JK, McLafferty RB, Ramsey DE, Solis MS, Gruneiro LA, Hodgson KJ. Pitfalls in achieving the Dialysis Outcome Quality Initiative (DOQI) guidelines for hemodialysis access?. Ann Vasc Surg. 2002;16:613–617
  24. Miller PE, Tolwani A, Luscy CP, et al. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int. 1999;56:275–280
  25. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions. Kidney Int. 2002;62:1109–1124
  26. Lok CE, Oliver MJ. Overcoming barriers to arteriovenous fistula creation and use. Semin Dial. 2003;16:189–196
  27. Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int. 2002;61:305–316
  28. Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002;39:92–101
  29. Segal JH, Kayler LK, Henke P, Merion RM, Leavey S, Campbell DA. Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis. 2003;42:151–157
  30. Fitzgerald JT, Schanzer A, Chin AI, McVicar JP, Perez RV, Troppmann C. Outcomes of upper arm arteriovenous fistulas for maintenance hemodialysis access. Arch Surg. 2004;139:201–208
  31. Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol. 2006;17:807–813
  32. Danese MD, Liu Z, Griffiths RI, et al. Catheter use is high even among hemodialysis patients with a fistula or graft. Kidney Int. 2006;70:1482–1485
  33. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL. Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis. 2004;44(suppl 2):S22–S26
  34. Yang R, Humphrey S. Review of arteriovenous fistula care. EDTNA ERCA J. 2000;26:11–14
  35. Ball LK. Improving arteriovenous fistula cannulation skills. Nephrol Nurs J. 2005;32:611–617
  36. Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. Am J Kidney Dis. 2005;46:501–508
  37. Silver MR, Cain JA. Managing the lifeline (Preemptive access management for better outcomes for hemodialysis patients and programs: Medical Review Board of the Renal Network, Inc). Adv Ren Replace Ther. 2000;7(suppl 1):S45–S55
  38. US Renal Data System. Excerpts from the USRDS 2003 Annual Data Report. Am J Kidney Dis. 2003;42(suppl 5):S1–S230
  39. US Renal Data System: USRDS 2006 Annual Data Report: Reference Tables—Section L (L.1). Available at: http://www.usrds.org/adr.htm. Accessed December 18, 2006
  40. Canaud B, Senecal L, Leray-Moragues H, et al. Vascular access, an underestimated source of inflammation in dialysis patients. Nephrologie. 2003;24:353–358
  41. Movilli E, Brunori G, Camerini C, et al. The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif. 2006;24:387–393
  42. Leblanc M, Bosc JY, Vaussenat F, Maurice F, Leray-Moragues H, Canaud B. Effective blood flow and recirculation rates in internal jugular vein twin catheters: Measurement by ultrasound velocity dilution. Am J Kidney Dis. 1998;31:87–92
  43. Level C, Lasseur C, Chauveau P, Bonarek H, Perrault L, Combe C. Performance of twin central venous catheters: Influence of the inversion of inlet and outlet on recirculation. Blood Purif. 2002;20:182–188
  44. Clase CM, Crowther MA, Ingram AJ, Cina CS. Thrombolysis for restoration of patency to haemodialysis central venous catheters: A systematic review. J Thromb Thrombolysis. 2001;11:127–136
  45. Zacharias JM, Weatherston CP, Spewak CR, Vercaigne LM. Alteplase versus urokinase for occluded hemodialysis catheters. Ann Pharmacother. 2003;37:27–33
  46. Grote J, Lufft V, Nikutta P, van der Lieth H, Bahlmann J, Daniel WG. Transesophageal echocardiographic assessment of superior vena cava thrombosis in patients with long-term central venous hemodialysis catheters. Clin Nephrol. 1994;42:183–188
  47. Kingdon EJ, Holt SG, Davar J, et al. Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis. 2001;38:631–639
  48. Madan AK, Allmon JC, Harding M, Cheng SS, Slakey DP. Dialysis access-induced superior vena cava syndrome. Am Surg. 2002;68:904–906
  49. Shapiro MA, Johnson M, Feinstein SB. A retrospective experience of right atrial and superior vena caval thrombi diagnosed by transesophageal echocardiography. J Am Soc Echocardiogr. 2002;15:76–79
  50. Criado E, Marston WA, Jaques PF, Mauro MA, Keagy BA. Proximal venous outflow obstruction in patients with upper extremity arteriovenous dialysis access. Ann Vasc Surg. 1994;8:530–535
  51. Hernandez D, Diaz F, Rufino M, et al. Subclavian vascular access stenosis in dialysis patients: Natural history and risk factors. J Am Soc Nephrol. 1998;9:1507–1510
  52. Jassal SV, Pierratos A, Roscoe JM. Venous stenosis and thrombosis associated with the use of internal jugular vein catheters for hemodialysis. ASAIO J. 1999;45:356–359
  53. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: Risk factors for failure. J Vasc Surg. 1997;26:1009–1019
  54. Little MA, O’Riordan A, Lucey B, et al. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant. 2001;16:2194–2200
  55. Allon M. Dialysis catheter-related bacteremia: Treatment and prophylaxis. Am J Kidney Dis. 2004;44:779–791
  56. Tokars JI, Miller ER, Stein G. New national surveillance system for hemodialysis-associated infections: Initial results. Am J Infect Control. 2002;30:288–295
  57. Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med. 1992;20:665–673
  58. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400–407
  59. Anaissie E, Samonis G, Kontoyiannis D, et al. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis. 1995;14:134–137
  60. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–193
  61. Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant. 2006;21:2184–2190
  62. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000;75:1008–1014
  63. Philipneri M, Al-Aly Z, Amin K, Gellens ME, Bastani B. Routine replacement of tunneled, cuffed, hemodialysis catheters eliminates paraspinal/vertebral infections in patients with catheter-associated bacteremia. Am J Nephrol. 2003;23:202–207
  64. Priest DH, Peacock JE. Hematogenous vertebral osteomyelitis due to Staphylococcus aureus in the adult: Clinical features and therapeutic outcomes. South Med J. 2005;98:854–862
  65. Abid Q, Price D, Stewart MJ, Kendall S. Septic pulmonary emboli caused by a hemodialysis catheter. Asian Cardiovasc Thorac Ann. 2002;10:251–253
  66. Dittmer ID, Tomson CR. Pulmonary abscess complicating central venous hemodialysis catheter infection. Clin Nephrol. 1998;49:66
  67. Suresh V, McGonigle RJ, Rowe PA, Tse WY. Bacterial meningitis—Complication from a dialysis catheter. Clin Nephrol. 2006;65:457–459
  68. Agraharkar M, Gokhale S, Cinclair R, Patel J, Gupta R. Panhemispheric infarction: A complication of cuffed catheter. South Med J. 2003;96:194–197
  69. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl. 2001;78:S206–S211
  70. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am. 2001;15:813–832
  71. Cohen G, Haag-Weber M, Horl WH. Immune dysfunction in uremia. Kidney Int Suppl. 1997;62:S79–S82
  72. Descamps-Latscha B, Chatenoud L. T Cells and B cells in chronic renal failure. Semin Nephrol. 1996;16:183–191
  73. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int. 1999;55:1081–1090
  74. US Renal Data System. Excerpts from the USRDS 2004 Annual Data Report. Am J Kidney Dis. 2004;45(suppl 1):S1–S270
  75. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60:1443–1451
  76. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620–626
  77. Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis. 2003;42:1013–1019
  78. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: A propensity score analysis. J Am Soc Nephrol. 2004;15:477–486
  79. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:469–477
  80. Metcalfe W, Khan IH, Prescott GJ, Simpson K, Macleod AM. Hospitalization in the first year of renal replacement therapy for end-stage renal disease. QJM. 2003;96:899–909
  81. Rayner HC, Pisoni RL, Bommer J, et al. Mortality and hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2004;19:108–120
  82. O’Connor AS, Wish JB, Sehgal AR. The morbidity and cost implications of hemodialysis clinical performance measures. Hemodial Int. 2005;9:349–361
  83. Nissenson AR, Dylan ML, Griffiths RI, et al. Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis. Am J Kidney Dis. 2005;46:301–308
  84. Manns B, Tonelli M, Yilmaz S, et al. Establishment and maintenance of vascular access in incident hemodialysis patients: A prospective cost analysis. J Am Soc Nephrol. 2005;16:201–209
  85. US Renal Data System. Excerpts from the USRDS 2006 Annual Data Report. Am J Kidney Dis. 2005;49(suppl 1):S1–S296
  86. Jennings W, Spergel L: CMS National Vascular Access Improvement Initiative. Available at: http://fistulafirst.org/concept.htm. Accessed December 20, 2006
  87. O’Hare AM, Dudley RA, Hynes DM, et al. Impact of surgeon and surgical center characteristics on choice of permanent vascular access. Kidney Int. 2003;64:681–689
  88. Sekkarie M. Increasing the placement of native veins arteriovenous fistulae—The role of access surgeons’ education and profiling. Clin Nephrol. 2004;62:44–48
  89. Beathard GA, Arnold P, Jackson J, Litchfield T. Physician Operators Forum of RMS Lifeline: Aggressive treatment of early fistula failure. Kidney Int. 2003;64:1487–1494
  90. Asif A, Cherla G, Merrill D, Cipleu CD, Briones P, Pennell P. Conversion of tunneled hemodialysis catheter-consigned patients to arteriovenous fistula. Kidney Int. 2005;67:2399–2406
  91. He C, Charoenkul V, Kahn T, Langhoff E, Uribarri J, Sedlacek M. Impact of the surgeon on the prevalence of arteriovenous fistulas. ASAIO J. 2002;48:39–40
  92. Nguyen VD, Griffith C, Treat L. A multidisciplinary team approach to increasing AV fistula creation. Nephrol News Issues. 2003;17:54–5658, 60
  93. Vassalotti JA, Falk A, Teodorescu V, Uribarri J. The multidisciplinary approach to hemodialysis vascular access at the Mount Sinai Hospital. Mt Sinai J Med. 2004;71:94–102
  94. Besarab A, Adams M, Amatucci S, et al. Unraveling the realities of vascular access: The Network 11 experience. Adv Ren Replace Ther. 2000;7(suppl 1):S65–S70
  95. Huber TS, Ozaki CK, Flynn TC, et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg. 2002;36:452–459
  96. Ascher E, Gade P, Hingorani A, et al. Changes in the practice of angioaccess surgery: Impact of Dialysis Outcome and Quality Initiative recommendations. J Vasc Surg. 2000;31:84–92
  97. Jennings WC. Creating arteriovenous fistulas in 132 consecutive patients: Exploiting the proximal radial artery arteriovenous fistula: Reliable, safe, and simple forearm and upper arm hemodialysis access. Arch Surg. 2006;141:27–32
  98. Robbin ML, Gallichio MH, Deierhoi MH, Young CJ, Weber TM, Allon M. US vascular mapping before hemodialysis access placement. Radiology. 2000;217:83–88
  99. Vassalotti JA, Falk A, Cohl ED, Uribarri J, Teodorescu V. Obese and non-obese hemodialysis patients have a similar prevalence of functioning arteriovenous fistula using pre-operative vein mapping. Clin Nephrol. 2002;58:211–214
  100. Arnold WP. Improvement in hemodialysis vascular access outcomes in a dedicated access center. Semin Dial. 2000;13:359–363
  101. Jackson JW, Lewis JL, Brouillette JR, Brantley RR. Initial experience of a nephrologist-operated vascular access center. Semin Dial. 2000;13:354–358
  102. Mishler R, Sands JJ, Ofsthun NJ, Teng M, Schon D, Lazarus JM. Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments. Kidney Int. 2006;69:393–398
  103. Kalman PG, Pope M, Bhola C, Richardson R, Sniderman KW. A practical approach to vascular access for hemodialysis and predictors of success. J Vasc Surg. 1999;30:727–733
  104. Spuhler CL, Schwarze KD, Sands JJ. Increasing AV fistula creation: The Akron experience. Nephrol News Issues. 2002;16:44–4750, 52
  105. Carlton D. The vascular access coordinator role: An interview with Donna Carlton by Betsy King. Nephrol Nurs J. 2005;32:688–690
  106. Waterhouse D. Vascular access: A role for a renal nurse clinician. EDTNA ERCA J. 2002;28:64–6669
  107. Kausz AT, Guo H, Pereira BJ, Collins AJ, Gilbertson DT. General medical care among patients with chronic kidney disease: Opportunities for improving outcomes. J Am Soc Nephrol. 2005;16:3092–3101
  108. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  109. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  110. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int. 2005;68:378–390
  111. Diaz-Buxo JA. Early referral and selection of peritoneal dialysis as a treatment modality. Nephrol Dial Transplant. 2000;15:147–149
  112. Stack AG. Determinants of modality selection among incident US dialysis patients: Results from a national study. J Am Soc Nephrol. 2002;13:1279–1287
  113. Ravani P, Marinangeli G, Stacchiotti L, Malberti F. Structured pre-dialysis programs: More than just timely referral?. J Nephrol. 2003;16:862–869
  114. Povlsen JV, Ivarsen P. How to start the late referred ESRD patient urgently on chronic APD. Nephrol Dial Transplant. 2006;21(suppl 2):Sii56–Sii59
  115. Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol. 2000;11:116–125
  116. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA. 2004;291:697–703
  117. Kutner NG, Zhang R, Barnhart H, Collins AJ. Health status and quality of life reported by incident patients after 1 year on haemodialysis or peritoneal dialysis. Nephrol Dial Transplant. 2005;20:2159–2167
  118. Foley RN, Guo H, Snyder JJ, Gilbertson DT, Collins AJ. Septicemia in the United States dialysis population, 1991 to 1999. J Am Soc Nephrol. 2004;15:1038–1045
  119. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 study. Kidney Int. 2005;68:311–318
  120. Bruns FJ, Seddon P, Saul M, Zeidel ML. The cost of caring for end-stage kidney disease patients: An analysis based on hospital financial transaction records. J Am Soc Nephrol. 1998;9:884–890
  121. Shih YC, Guo A, Just PM, Mujais S. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients. Kidney Int. 2005;68:319–329
  122. Panagoutsos S, Kantartzi K, Passadakis P, et al. Timely transfer of peritoneal dialysis patients to hemodialysis improves survival rates. Clin Nephrol. 2006;65:43–47
  123. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int. 1997;17:360–364
  124. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: A multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9:869–876
  125. Taylor G, Gravel D, Johnston L, et al. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control. 2004;32:155–160
  126. Astor BC, Eustace JA, Powe NR, et al. Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16:1449–1455
  127. Schwartz AB, DeClement FA, Bower R, Chinitz JL, Lyons H, Capaldo RA. Conversion of external arteriovenous hemodialysis shunt to internal fistula. JAMA. 1978;239:1782–1783
  128. Sigley RD, May KJ, Mack RM. Scribner shunt conversion to arteriovenous fistula. Am J Surg. 1979;137:423–424
  129. Murthy ML, Niyamathullah MM, Hariharan S, Kirubakaran MG, Shastry JC. Conversion of arteriovenous shunts to fistulae for maintenance haemodialysis: Its applicability in a developing country. J Assoc Physicians India. 1989;37:220–221
  130. Haruguchi H, Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: A review. J Artif Organs. 2003;6:227–235
  131. Abeles D, Kwei S, Stavrakis G, Zhang Y, Wang ET, Garcia-Cardena G. Gene expression changes evoked in a venous segment exposed to arterial flow. J Vasc Surg. 2006;44:863–870
  132. Hofstra L, Bergmans DC, Leunissen KM, Hoeks AP, Kitslaar PJ, Tordoir JH. Prosthetic arteriovenous fistulas and venous anastomotic stenosis: Influence of a high flow velocity on the development of intimal hyperplasia. Blood Purif. 1996;14:345–349
  133. Nguyen VD, Griffith C. Successful conversion of dialysis grafts into secondary AV fistula (A three year experience at Providence St. Peter Hospital dialysis program). J Am Soc Nephrol. 2000;11:193A;(abstr)
  134. Beathard GA. Interventionalist’s role in identifying candidates for secondary fistulas. Semin Dial. 2004;17:233–236
  135. Jefic D, Reddy PP, Flynn LM, Provenzano R. A single center experience in the use of polyurethaneurea arteriovenous grafts. Nephrol News Issues. 2005;19:44–47
  136. Scher LA, Katzman HE. Alternative graft materials for hemodialysis access. Semin Vasc Surg. 2004;17:19–24
  137. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: Risk factors for failure. J Vasc Surg. 1997;26:1009–1019
  138. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004;39:73–78
  139. Minga TE, Flanagan KH, Allon M. Clinical consequences of infected arteriovenous grafts in hemodialysis patients. Am J Kidney Dis. 2001;38:975–978
  140. Tabbara MR, O’Hara PJ, Hertzer NR, Krajewski LP, Beven EG. Surgical management of infected PTFE hemodialysis grafts: Analysis of a 15-year experience. Ann Vasc Surg. 1995;9:378–384
  141. Deneuville M. Infection of PTFE grafts used to create arteriovenous fistulas for hemodialysis access. Ann Vasc Surg. 2000;14:473–479
  142. Brouwer D. Needle placement is paramount to achieving effective dialysis and preserving vascular accesses. Nephrol Nurs J. 2005;32:225–227
  143. Patel KR, Chan FA, Batista RJ, Clauss RH. True venous aneurysms and arterial “steal” secondary to arteriovenous fistulae for dialysis. J Cardiovasc Surg. 1992;33:185–188(Torino)
  144. Ball LK. The buttonhole technique for arteriovenous fistula cannulation. Nephrol Nurs J. 2006;33:299–304
  145. Quinn-Cefaro R. Developing a self-cannulation program. ANNA J. 1999;26:344;343
  146. Bednar B, Steinman TI, Street J. Changing the operating structure. Nephrol News Issues. 2002;16:25–28
  147. Trerotola SO, Scheel PJ, Powe NR, et al. Screening for dialysis access graft malfunction: Comparison of physical examination with US. J Vasc Interv Radiol. 1996;7:15–20
  148. Tessitore N, Bedogna V, Poli A. The role of surveillance in mature arteriovenous fistula management. J Vasc Access. 2004;5:57–61
  149. Wijnen E, Planken N, Keuter X, et al. Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure. Nephrol Dial Transplant. 2006;21:3514–3519
  150. Shahin H, Reddy G, Sharafuddin M, Katz D, Franzwa BS, Dixon BS. Monthly access flow monitoring with increased prophylactic angioplasty did not improve fistula patency. Kidney Int. 2005;68:2352–2361
  151. Tessitore N, Lipari G, Poli A, et al. Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? (A randomized controlled study). Nephrol Dial Transplant. 2004;19:2325–2333
  152. Tonelli M, Hirsch D, Clark TW, et al. Access flow monitoring of patients with native vessel arteriovenous fistulae and previous angioplasty. J Am Soc Nephrol. 2002;13:2969–2973
  153. McCarley P, Wingard RL, Shyr Y, Pettus W, Hakim RM, Ikizler TA. Vascular access blood flow monitoring reduces access morbidity and costs. Kidney Int. 2001;60:1164–1172
  154. Hingorani A, Ascher E, Kallakuri S, Greenberg S, Khanimov Y. Impact of reintervention for failing upper-extremity arteriovenous autogenous access for hemodialysis. J Vasc Surg. 2001;34:1004–1009
  155. Turmel-Rodrigues L, Pengloan J, Baudin S, et al. Treatment of stenosis and thrombosis in haemodialysis fistulas and grafts by interventional radiology. Nephrol Dial Transplant. 2000;15:2029–2036
  156. Bittl JA, Feldman RL. Prospective assessment of hemodialysis access patency after percutaneous intervention: Cox proportional hazards analysis. Catheter Cardiovasc Interv. 2005;66:309–315

 Originally published online as doi: 10.1053/j.ajkd.2007.06.006 on August 6, 2007.

PII: S0272-6386(07)00926-2

doi: 10.1053/j.ajkd.2007.06.006

American Journal of Kidney Diseases
Volume 50, Issue 3 , Pages 379-395 , September 2007

Article Tools

* Image Usage & Resolution